Measurement of Tumour Nuclear Area by Artificial Intelligence is Associated with Residual Cancer Burden Index After Neoadjuvant Chemotherapy in Estrogen Receptor Positive Breast Cancer

被引：0
|
作者：
Dodington, David [1 ]
Lagree, Andrew [2 ]
Tabbarah, Sami [2 ]
Mohebpour, Majidreza [2 ]
Sadeghi-Naini, Ali [3 ]
Tran, William [4 ]
Lu, Fang-I [4 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Sunnybrook Res Inst, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[4] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
来源：
LABORATORY INVESTIGATION | 2021年 / 101卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
85
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [1] Measurement of Tumour Nuclear Area by Artificial Intelligence is Associated with Residual Cancer Burden Index After Neoadjuvant Chemotherapy in Estrogen Receptor Positive Breast Cancer
    Dodington, David
    Lagree, Andrew
    Tabbarah, Sami
    Mohebpour, Majidreza
    Sadeghi-Naini, Ali
    Tran, William
    Lu, Fang-I
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 94 - 94
  • [2] Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
    Symmans, W. Fraser
    Peintinger, Florentia
    Hatzis, Christos
    Rajan, Radhika
    Kuerer, Henry
    Valero, Vicente
    Assad, Lina
    Poniecka, Anna
    Hennessy, Bryan
    Green, Marjorie
    Buzdar, Aman U.
    Singletary, S. Eva
    Hortobagyi, Gabriel N.
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) : 4414 - 4422
  • [3] The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
    Xu, Xin
    Zhao, Wei
    Liu, Cuicui
    Gao, Yongsheng
    Chen, Dawei
    Wu, Meng
    Li, Chao
    Wang, Xinzhao
    Song, Xiang
    Yu, Jinming
    Liu, Zhaoyun
    Yu, Zhiyong
    BMC CANCER, 2024, 24 (01)
  • [4] The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
    Xin Xu
    Wei Zhao
    Cuicui Liu
    Yongsheng Gao
    Dawei Chen
    Meng Wu
    Chao Li
    Xinzhao Wang
    Xiang Song
    Jinming Yu
    Zhaoyun Liu
    Zhiyong Yu
    BMC Cancer, 24
  • [5] Residual Cancer Burden After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Elder, E. A.
    Livasy, C.
    Donahue, E.
    Neelands, B. J.
    Patrick, A.
    Needham, M.
    Sarantou, T.
    Hadzikadic-Gusic, L.
    White, R.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S53 - S53
  • [6] Noninvasive Artificial Intelligence System for Early Predicting Residual Cancer Burden During Neoadjuvant Chemotherapy in Breast Cancer
    Li, Wei
    Huang, Yu-Hong
    Zhu, Teng
    Zhang, Yi-Min
    Zheng, Xing-Xing
    Zhang, Ting-Feng
    Lin, Ying-Yi
    Wu, Zhi-Yong
    Liu, Zai-Yi
    Lin, Ying
    Ye, Guo-Lin
    Wang, Kun
    ANNALS OF SURGERY, 2025, 281 (04) : 645 - 654
  • [7] Neoadjuvant chemotherapy is not associated with improved survival for estrogen receptor positive/negative breast cancer
    Johnson, Jeffrey
    Barmparas, Galinos
    Chung, Alice
    Manguso, Nicholas
    Giuliano, Armando
    Amersi, Farin
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 138 - 139
  • [8] Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy
    Peintinger, Florentia
    Sinn, Bruno
    Hatzis, Christos
    Albarracin, Constance
    Downs-Kelly, Erinn
    Morkowski, Jerzy
    Gould, Rebekah
    Symmans, W. Fraser
    MODERN PATHOLOGY, 2015, 28 (07) : 913 - 920
  • [9] Factors associated with mastectomy in women with small residual tumour after neoadjuvant chemotherapy for breast cancer
    Bernell, E.
    Duinmeijer, A.
    Altena, R.
    Foukakis, T.
    Fredholm, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S54 - S54
  • [10] Pathological measurement and staging of residual breast cancer after neoadjuvant chemotherapy
    Harter, Dawn
    O'Connor, Siobhan M.
    Hertel, Johann D.
    Calhoun, Benjamin C.
    HISTOPATHOLOGY, 2023, 83 (03) : 453 - 464
12345